Subclinical hypothyroidism and the risk of coronary heart disease and mortality

JAMA

Volumn 304, Issue 12, 2010, Pages 1365-1374

  Rodondi, Nicolas ^a   Den Elzen, Wendy P J ^b   Bauer, Douglas C ^c,d   Cappola, Anne R ^e   Razvi, Salman ^f   Walsh, John P ^g,h   Åsvold, Bjørn O ^j   Iervasi, Giorgio ^k   Imaizumi, Misa ^l   Collet, Tinh Hai ^a   Bremner, Alexandra ⁱ   Maisonneuve, Patrick ^m   Sgarbi, José A ^n,o   Khaw, Kay Tee ^p   Vanderpump, Mark P J ^q   Newman, Anne B ^r   Cornuz, Jacques ^a   Franklyn, Jayne A ^s   Westendorp, Rudi G J ^b,t   Vittinghoff, Eric ^c   Gussekloo, Jacobijn ^b   more..

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f GATESHEAD HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^g SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^k INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^l RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^m EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

ⁿ FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^o FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q ROYAL FREE HOSPITAL   (United Kingdom)

^r UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^s UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^t Netherlands Consortium for Healthy Ageing   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; ADOLESCENT; AGED; BLOOD; COMPLICATION; CORONARY ARTERY DISEASE; MIDDLE AGED; PROSPECTIVE STUDY; RISK; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CORONARY DISEASE; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDIES; RISK; THYROTROPIN; YOUNG ADULT;

EID: 77956928569     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1361     Document Type: Article

References (45)

1. Helfand M; US Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults. Ann Intern Med. 2004;140(2): 128-141.
2. SurksMI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease. JAMA. 2004;291(2):228-238.
3. Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction. J Clin Endocrinol Metab. 2005; 90(1):581-585.
4. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008; 29(1):76-131.
5. Hak AE, Pols HA, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women. Ann Intern Med. 2000;132(4):270-278.
6. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295(9):1033-1041.
7. Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005;165(21):2460-2466.
8. Iervasi G, Molinaro S, Landi P, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med. 2007; 167(14):1526-1532.
9. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165(21): 2467-2472.
10. Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148(11):832-845.
11. Razvi S, Shakoor A, Vanderpump M, et al. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease. J Clin Endocrinol Metab. 2008;93(8):2998-3007.
12. Völzke H, Schwahn C, Wallaschofski H, Dörr M. Review: the association of thyroid dysfunction with all-cause and circulatory mortality. J Clin Endocrinol Metab. 2007;92(7):2421-2429.
13. Egger M, Davey Smith G, Altman D. Systematic Reviews in Health Care: Meta-analysis in Context. London, England: BMJ Publishing Group; 2001.
14. Simmonds MC, Higgins JP, Stewart LA, et al. Metaanalysis of individual patient data from randomized trials. Clin Trials. 2005;2(3):209-217.
15. Rodondi N, Bauer DC, Cappola AR, et al. Sub-clinical thyroid dysfunction, cardiac function, and the risk of heart failure. J Am Coll Cardiol. 2008;52 (14):1152-1159.
16. Nicoloff JT, Spencer CA. Clinical review 12: the use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab. 1990;71(3):553-558.
17. Vanderpump MP, Tunbridge WM, French JM, et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid. 1996;6(3):155-160.
18. Razvi S, Weaver JU, Vanderpump MP, Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab. 2010;95(4):1734-1740.
19. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994). J Clin Endocrinol Metab. 2002;87(2):489-499.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
22. Stewart LA, Clarke MJ; Cochrane Working Group. Practical methodology of meta-analyses (overviews) using updated individual patient data. Stat Med. 1995; 14(19):2057-2079.
23. Fowkes FG, Murray GD, Butcher I, et al; Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality. JAMA. 2008;300 (2):197-208.
24. Riley RD, Simmonds MC, Look MP. Evidence synthesis combining individual patient data and aggregate data. J Clin Epidemiol. 2007;60(5):431-439.
25. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-560.
26. Parle JV, Maisonneuve P, Sheppard MC, et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result. Lancet. 2001;358(9285):861-865.
27. Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21):2591-2599.
28. Heinze G, Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics. 2001;57(1):114-119.
29. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994; 331(19):1249-1252.
30. Vittinghoff E, Glidden D, Shiboski S, McCulloch C. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. New York, NY: Springer-Verlag; 2005.
31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
32. Boekholdt SM, Titan SM, Wiersinga WM, et al. Initial thyroid status and cardiovascular risk factors. Clin Endocrinol (Oxf ). 2010;72(3):404-410.
33. Asvold BO, Bjøro T, Nilsen TI, Gunnell D, Vatten LJ. Thyrotropin levels and risk of fatal coronary heart disease. Arch Intern Med. 2008;168(8):855-860.
34. Imaizumi M, Akahoshi M, Ichimaru S, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89(7):3365-3370.
35. Sgarbi JA, Matsumura LK, Kasamatsu TS, et al. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up. Eur J Endocrinol. 2010;162(3):569-577.
36. Ladenson PW. Cardiovascular consequences of subclinical thyroid dysfunction. Ann Intern Med. 2008; 148(11):880-881.
37. Cooper DS. Thyroid disease in the oldest old. JAMA. 2004;292(21):2651- 2654.
38. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7): 501-509.
39. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725-1735.
40. Monzani F, Caraccio N, Kozàkowà M, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004; 89(5):2099-2106.
41. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community. Clin Endocrinol (Oxf ). 1995;43(1): 55-68.
42. Stroup DF, Berlin JA, Morton SC, et al. Metaanalysis of observational studies in epidemiology. JAMA. 2000;283(15):2008-2012.
43. Razvi S, Ingoe L, Keeka G, et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism. J Clin Endocrinol Metab. 2007; 92(5):1715-1723.
44. Fatourechi V, Lankarani M, Schryver PG, et al. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L). Mayo Clin Proc. 2003; 78(5):554-560.
45. Cappola AR. Subclinical thyroid dysfunction and the heart. J Clin Endocrinol Metab. 2007;92(9): 3404-3405.